Torrey Pines Law Group is an intellectual property (IP), technology transactions, and FDA regulatory law firm. We opened our San Diego office in 2013, and our Los Angeles and Irvine offices in 2020. Our Boston office was founded in 2024. Our patent preparation & prosecution, international technology transactions, and FDA regulatory practices are considered to be some of the best in the United States. We are driven to help you bring impactful -- and often lifesaving -- technologies to market worldwide by securing, building, and defending your competitive advantage.
Our team members have an average of 20 years of experience in the legal profession, and many are thought leaders in their scientific and technical fields as well as in their businesses and legal practices.
Most of our colleagues have experience embedded within large technology, pharmaceutical, biotechnology, and MedTech corporations. Many have held executive positions including General Counsel, Director, Officer, or other in-house executive positions inside publicly traded companies, agile startups, large universities, and government agencies.
Many of us are also active investors where we translate real-world experience into value-generating legal and business strategies. All of this exceptional experience fuels our ability to translate healthcare, life sciences, pharmaceutical, biotechnology, digital health, precision medicine, diagnostics, software, and high technology from concept to market.
Since our founding in 2013, we have become regarded as one of the best patent law firms in the United States for advising on international IP rights at the intersection of artificial intelligence (AI), biotechnology, in vitro diagnostics (IVD), medical device, and pharmaceutical innovations. With the addition of a number of software, semiconductor, laser & optics, telecommunications, and telemedicine attorneys in 2024, our team has become a comprehensive resource to our clients innovating in the hardware, software, healthcare, life sciences, and convergence technology ecosystem.
For many years, we have been selected by The Patent Lawyer magazine as one of the Top Ten West Coast IP and Patent Law Firms.
Our clients include the spectrum from large publicly traded companies and leading technology and life sciences companies to major universities and private research institutes, startups, and individual entrepreneurs.
Our team is fluent in the languages of technology, business, and the law. We are able to successfully translate between those fields into actionable business strategies that impact your bottom line. In addition, we are business owners, investors, and entrepreneurs. We understand the day-to-day pressures and rewards that accompany high-level implementation of commercial strategy within innovative companies.
Our individual practitioners have successfully advised our clients through the maze of legal and commercial issues that arise in connection with the acquisition, development, adoption, and commercialization of new technologies and IP assets in a wide range of cutting-edge industries in the United States, Europe, and Asia.
Specifically, we are experts with drafting, negotiating and advising our clients with respect to international technology transactions, corporate strategy, business agreements, transactional due diligence, intellectual property agreements, intellectual property due diligence, regulatory agreements, and regulatory due diligence.
Our team structures and negotiates agreements and provides sophisticated business advice on the legal and commercial issues that arise in complex multijurisdictional technology and IP-related transactions, including mergers and acquisitions, patent licensing and valuation, SaaS, reseller, quality agreements, pharmacovigilance agreements, and development, collaboration, joint-venture, and distribution deals.
Torrey Pines Law Group's regulatory attorneys and advisors have substantial experience providing global strategic advice regarding FDA regulatory, Digital Health laws, international privacy regulations, and public policy.
Our global FDA regulatory practice focuses on mitigating risk while also assessing the nuance between multijurisdictional markets which enhances the potential of a successful product launch.
Our team has substantial experience with all facets of the international regulatory approval and clearance processes including dossier submissions, Quality Compliance (ISO), CE Mark, MDR, Digital Health, Hatch-Waxman & Biosimilars, Labeling, Advertising & Promotion, and Reimbursement & Health Economics.
Each of our team leaders has more than 20 years of experience with technology commercialization.
We understand that the successful implementation of each of these solutions is required to provide value to your venture. These solutions also require thoughtful coordination, and our strategies are intended to evolve with your business goals. This integrated approach provides our clients the support they need to take their life sciences and healthcare products from concept to market.
What distinguishes us, however, is our ability to synthesize comprehensive go-to-market legal and business strategies. The foundation for our approach is understanding that the alignment of your R&D and/or clinical strategy, your IP strategy, your corporate strategy, commercial transactions, in addition to your regulatory and compliance strategy -- and so forth -- is critical to your business success. That arena is large and complex, and because we effectively translate between the languages of science, business, and the law, we are able to accomplish what few other law firms are able to accomplish.
Our firm focuses on coordinating the international aspects of the technology commercialization process including:
We welcome the opportunity to provide you more detailed information about our firm and see how we can work together. Please contact us to schedule a free initial consultation, and interact with us on LinkedIn®, Yelp®, and Facebook®.
COPYRIGHT ©
, TORREY PINES LAW GROUP, PC. ALL RIGHTS RESERVED. | LEGAL NOTICES | SITE MAP | PAYMENTS | STANDARD FIRM CHARGES
Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.
We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.
San Diego Intellectual Property Law Firm - Orange County FDA Regulatory Counsel - Los Angeles Technology Transactions - International Patent Preparation & Prosecution - Complex IP Transactions - IP and Investment Due Diligence Attorneys - Biotechnology Patent Lawyers - Pharmaceutical Lifecycle Management - Medical Device Patent Counsel - Artificial Intelligence - Digital Health